Third party beauty and personal care manufacturer Naturis Cosmetics has raised Rs 100 crore in its first institutional funding round led by Sharrp Ventures, the investment office of the Marico promoter family. The round also saw participation from Mirabilis Investment Trust, representing the family office of Infosys co founder K. Dinesh, along with Anicut Capital and Niveshaay.
The deal also included contributions from ecosystem operators such as Hyperscale Ventures founder Suyash Saraf and Yogesh Kabra, plus select angel investors from the pharmaceutical and specialty chemicals sectors.
Backend Manufacturing
While consumer facing beauty brands have historically attracted venture capital, investor interest is now shifting toward backend manufacturing and supply chain infrastructure.
Naturis operates as an R&D driven contract development and manufacturing organization, serving as the outsourced production engine for more than 50 major beauty and personal care brands. These include Nykaa, Pilgrim, Purplle, Colorbar, Bare Anatomy, Kay Beauty, and Asaya.
Beyond cosmetics, Naturis also has long term supply partnerships with pharmaceutical firms such as Glenmark and Dr. Reddy’s Laboratories, producing over the counter and cosmeceutical products.
Capital Deployment
The new capital will be used for physical and technological expansion. Naturis plans to set up a new manufacturing plant in Vapi to increase production volumes. Alongside this, it will establish an experience centre in the National Capital Region and a new R&D hub in Mumbai.
This funding will help company to strengthen its R&D capabilities, expand manufacturing capacity, and accelerate its vision.— Rahul Tandon, CEO, Naturis Cosmetics
This expansion will help the company enter new product categories in the coming months, broadening its portfolio across beauty, personal care, and specialized over the counter formulations.
Financial Growth
The investment follows a period of financial growth for the contract manufacturer. Although the company is yet to formally file its FY26 financial statements, its operating revenue grew by roughly 40% to Rs 154 crore in FY25, up from Rs 110 crore in the preceding fiscal year.
Net profit for the same period was recorded at Rs 12 crore. According to financial data provided by the company, it has maintained a compound annual growth rate of more than 50% over the last four fiscal years while remaining consistently profitable.
"The funding will help the company strengthen its R&D capabilities, expand manufacturing capacity, and accelerate its vision of building a leading beauty and personal care manufacturing platform in India," said Rahul Tandon, co-founder and CEO of Naturis Cosmetics.
The capital infusion reflects a broader structural shift in the domestic beauty manufacturing market, where traditional B2B players are turning to institutional capital to institutionalize their operations, upgrade technology, and meet the high-volume, rapid-delivery demands of modern direct-to-consumer brands.
About Company
Naturis Cosmetics is a domestic contract development and manufacturing organization focused on beauty, personal care, and wellness. Founded as an R&D driven business, it provides formulation, product development, packaging, and manufacturing services to more than 50 brands, consumer groups, and pharmaceutical companies.
By running specialized facilities, Naturis supports production across skincare, haircare, and cosmeceuticals.
With strong growth, profits, and partnerships across consumer and pharma sectors, the company is ready to expand into new categories. The funding will help Naturis scale production, boost R&D, and meet rising demand from direct to consumer brands, making it a key player in India evolving beauty ecosystem.
